Current filters:


1 to 9 of 342 results

Takeda Pharma considering expansion in Russia and other BRIC countries


Amid the falling dynamics in the European Union and the USA, Japan's largest drugmaker Takeda Pharmaceutical…

EuropeGlobalMarkets & MarketingNycomedPharmaceuticalTakeda Pharmaceuticals

Takeda completes 75 million-euro Russian pharmaceutical production plant


Takeda Pharmaceutical International GmbH said this morning that it has completed the construction at…

EuropeNycomedPharmaceuticalProductionTakeda Pharmaceuticals

Nycomed debuts Omnaris nasal spray in the UAE


Nycomed, a subsidiary of Japanese drug major Takeda Pharmaceuticals (TYO: 4502), said yesterday that…

Markets & MarketingNycomedOmnarisPharmaceuticalRespiratory and PulmonaryRest of the WorldTakeda Pharmaceuticals

EU Commission finds no evidence against AstraZeneca and Nycomed


The European Commission said yesterday that it has ceased its antitrust investigation into the pharmaceutical…

AstraZenecaEuropeLegalNycomedPatentsPharmaceuticalRegulationTakeda Pharmaceuticals

Costs take toll on earnings from Japan’s Takeda


Japan’s largest drugmaker, Takeda Pharmaceutical (TSE: 4502), yesterday released consolidated results…

FinancialNycomedPharmaceuticalTakeda Pharmaceuticals

Takeda cuts 2,800 jobs as it assimilates Nycomed


Japan’s largest drugmaker Takeda Pharmaceutical (TSE: 4502) yesterday announced strategic measures…

FinancialManagementNycomedPharmaceuticalResearchTakeda Pharmaceuticals

Takeda ends Daxas co-promotion with MSD; Actos law suits


Japan’s largest drugmaker, Takeda Pharmaceuticals (TYO: 4502) says that it has reached a mutual…

ActosDaxasDiabetesLegalLicensingMerck & CoNycomedPharmaceuticalRespiratory and PulmonaryTakeda Pharmaceuticals

1 to 9 of 342 results

Back to top